NCT00402883 2021-11-09
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Terminated
SCRI Development Innovations, LLC
Spectrum Pharmaceuticals, Inc
Stanford University
National Cancer Institute (NCI)